DMTC has held another successful Student Conference, with scholarship recipients gathering in Melbourne on 2 November.
Our annual student conference is conducted in partnership with the Research Training Centre for Naval Design and Manufacturing (RTCNDM) and the Defence Science Institute. The focus of the conference is to give PhD and Masters candidates the opportunity to professionally present on the progress and conclusions of their research work to their peers and to continue to develop their presentation and communication skills. This year’s conference topics were wide-ranging, with everything from inspection robotics to immunology to additive manufacturing of cutting tools, and more.
More information about the 2017 Conference including presentation abstracts is available here.
Some of the presenters from this year’s Conference (l-r) Panneer Ponnusamy (Swinburne), Rowan Pivetta (Flinders) and Emily Kibble (UWA Murdoch).
On 29 September the Minister for Defence Industry, the Hon Christopher Pyne MP, announced the first round of the DMTC High Altitude Sensor Systems program including four projects, with work expected to commence before the end of the 2017 calendar year.
A number of organisations across Australia, comprising innovative commercial enterprises and leading Universities and research agencies, will come together under the DMTC program.
DMTC industry partner Anteo Diagnostics Ltd has notified the ASX of the successful completion of the first milestone in their DMTC project, with initial studies demonstrating high-detection sensitivity.
Anteo has partnered with Planet Innovation, Deakin University and DMTC to further the technology readiness of Planet Innovation’s (Nplex) low cost, high sensitivity point of care diagnostic system using breakthrough reader technology.
Anteo’s contribution and objectives in Milestone 1 were to successfully functionalise nanoparticles requiring integration with Planet Innovation’s reader. Anteo has successfully established, optimised and verified a model lateral flow system for the nominated target assay using Mix&Go.
Work on the next milestone is already underway and is scheduled to be completed by next quarter.
The DMTC Medical Countermeasures (MCM) program recognises the increasingly important need to create, in Australia, an integrated multidisciplinary network focused on MCM product development.
